ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation
A multi-center, randomized, double-blind, placebo-controlled, 4-arm clinical study to evaluate efficacy and safety of nicotine lozenge (2mg and 4mg) in smoking cessation in adult cigarette smokers who are motivated to quit smoking. Successful quitters or participants who smoke occasionally will be followed up after week 24 till 12 months.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers#1152065
- Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment#853375
- Tobacco Intervention in Primary Care Treatment Opportunities for Providers#832557
- Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch#886013
- Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation#833583
Record · ID 1370682
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive